| GC33815-100mg |
|
156-38-7 |
4-Hydroxyphenylacetic acid
|
0 |
C8H8O3 |
|
|
|
| GC33814-1g |
|
110-94-1 |
|
0 |
C5H8O4 |
|
|
|
| GC33813-20mg |
|
1071970-13-2 |
Xanthine oxidase-IN-1 (4-(3-Cyano-5,6-difluoroindol-1-yl)-2-hydroxybenzoic acid)
|
0 |
C16H8F2N2O3 |
|
|
|
| GC33813-10mg |
|
1071970-13-2 |
Xanthine oxidase-IN-1 (4-(3-Cyano-5,6-difluoroindol-1-yl)-2-hydroxybenzoic acid)
|
0 |
C16H8F2N2O3 |
|
|
|
| GC33813-5mg |
|
1071970-13-2 |
Xanthine oxidase-IN-1 (4-(3-Cyano-5,6-difluoroindol-1-yl)-2-hydroxybenzoic acid)
|
0 |
C16H8F2N2O3 |
|
|
|
| GC33813-1mg |
|
1071970-13-2 |
Xanthine oxidase-IN-1 (4-(3-Cyano-5,6-difluoroindol-1-yl)-2-hydroxybenzoic acid)
|
0 |
C16H8F2N2O3 |
|
|
|
| GC33812-50mg |
|
138529-46-1 |
Biotin-DADOO (Biotinyl-3,6-dioxaoctanediamine)
|
0 |
C16H30N4O4S |
|
|
|
| GC33812-10mg |
|
138529-46-1 |
Biotin-DADOO (Biotinyl-3,6-dioxaoctanediamine)
|
0 |
C16H30N4O4S |
|
|
|
| GC33812-10mM(1mLinDMSO) |
|
138529-46-1 |
Biotin-DADOO (Biotinyl-3,6-dioxaoctanediamine)
|
0 |
C16H30N4O4S |
|
|
|
| GC33811-1g |
|
111-16-0 |
Pimelic acid (1,5-Pentanedicarboxylic acid)
|
0 |
C7H12O4 |
|
|
|
| GC33811-10mM(1mLinDMSO) |
|
111-16-0 |
Pimelic acid (1,5-Pentanedicarboxylic acid)
|
0 |
C7H12O4 |
|
|
|
| GC33810-25mg |
|
362-08-3 |
|
0 |
C19H24O3 |
|
|
|
| GC33810-10mg |
|
362-08-3 |
|
0 |
C19H24O3 |
|
|
|
| GC33810-5mg |
|
362-08-3 |
|
0 |
C19H24O3 |
|
|
|
| GC33809-10mg |
|
162704-20-3 |
|
0 |
C23H24N2O7S |
|
|
|
| GC33809-5mg |
|
162704-20-3 |
|
0 |
C23H24N2O7S |
|
|
|
| GC33809-1mg |
|
162704-20-3 |
|
0 |
C23H24N2O7S |
|
|
|
| GC33808-50mg |
|
1610800-25-3 |
Diacylglycerol acyltransferase inhibitor-1
|
0 |
C21H23N5O2 |
|
|
|
| GC33808-25mg |
|
1610800-25-3 |
Diacylglycerol acyltransferase inhibitor-1
|
0 |
C21H23N5O2 |
|
|
|
| GC33808-10mg |
|
1610800-25-3 |
Diacylglycerol acyltransferase inhibitor-1
|
0 |
C21H23N5O2 |
|
|
|
